Debt-to-equity in % of Medpace Holdings, Inc. from Q2 2017 to Q3 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Medpace Holdings, Inc. quarterly Debt-to-equity history and change rate from Q2 2017 to Q3 2025.
Medpace Holdings, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 288 %, a 81.1% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Medpace Holdings, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	288	+129	+81.1%	30 Sep 2025
Q2 2025	210	+31.2	+17.5%	30 Jun 2025
Q1 2025	161	-42.1	-20.7%	31 Mar 2025
Q4 2024	151	-84.8	-35.9%	31 Dec 2024
Q3 2024	159	-94.3	-37.2%	30 Sep 2024
Q2 2024	178	-93.6	-34.4%	30 Jun 2024
Q1 2024	203	-91.2	-31%	31 Mar 2024
Q4 2023	236	+7.54	+3.3%	31 Dec 2023
Q3 2023	254	+95.8	+60.7%	30 Sep 2023
Q2 2023	272	+157	+136%	30 Jun 2023
Q1 2023	295	+212	+255%	31 Mar 2023
Q4 2022	229	+156	+214%	31 Dec 2022
Q3 2022	158	+85.3	+118%	30 Sep 2022
Q2 2022	115	+45.8	+65.8%	30 Jun 2022
Q1 2022	82.9	+15.1	+22.3%	31 Mar 2022
Q4 2021	72.9	+7.61	+11.7%	31 Dec 2021
Q3 2021	72.5	+11.1	+18.1%	30 Sep 2021
Q2 2021	69.5	+10.3	+17.5%	30 Jun 2021
Q1 2021	67.8	+11.4	+20.2%	31 Mar 2021
Q4 2020	65.3	+8.19	+14.3%	31 Dec 2020
Q3 2020	61.4	+2.95	+5.05%	30 Sep 2020
Q2 2020	59.2	-2.62	-4.24%	30 Jun 2020
Q1 2020	56.4	-11.4	-16.9%	31 Mar 2020
Q4 2019	57.1	-17.1	-23%	31 Dec 2019
Q3 2019	58.4	-22.1	-27.4%	30 Sep 2019
Q2 2019	61.8	-19.7	-24.2%	30 Jun 2019
Q1 2019	67.8	-8.03	-10.6%	31 Mar 2019
Q4 2018	74.2	+6.57	+9.72%	31 Dec 2018
Q3 2018	80.5	+19.1	+31%	30 Sep 2018
Q2 2018	81.5	+22.9	+39.1%	30 Jun 2018
Q1 2018	75.9			31 Mar 2018
Q4 2017	67.6			31 Dec 2017
Q3 2017	61.5			30 Sep 2017
Q2 2017	58.6			30 Jun 2017

* An asterisk sign (*) next to the value indicates that the value is likely invalid.